Act like a MDS Pedodontics professor and frame an essay for the topic . Discuss the role of saliva in preventing oral diseases. OR Saliva and Oral Health. Use the above uploaded articles. Also add recent studies and developments in the field with proper references.

Reading File

Searching PubMed

saliva oral health protective mechanisms

Reading File

Searching PubMed

saliva dental caries children antimicrobial

Searching PubMed

salivary biomarkers oral cancer diagnosis

Running Command

python3 -c " import pdfplumber pdfs = [ '/home/daytona/workspace/attachments/a8472a50-6a5f-4d52-a2de-556386979d7c/medoralv11i5p449.pdf', '/home/daytona/workspace/attachments/a8472a50-6a5f-4d52-a2de-556386979d7c/cancers-16-04276.pdf', '/home/daytona/workspace/attachments/a8472a50-6a5f-4d52-a2de-556386979d7c/The_composition_function_and_role_of_sal.pdf', ] for pdf_path in pdfs: print(f'\n\n===== {pdf_path.split(\"/\")[-1]} =====\n') with pdfplumber.open(pdf_path) as pdf: for i, page in enumerate(pdf.pages[:6]): text = page.extract_text() if text: print(f'--- Page {i+1} ---') print(text[:2000]) print() "

Searching PubMed

saliva xerostomia pediatric oral microbiome

Searching PubMed

salivary IgA periodontal disease immunity

Running Command

python3 -c " import pdfplumber # Get more pages from cancers PDF (pages 7-15) and the third PDF pdfs = [ ('/home/daytona/workspace/attachments/a8472a50-6a5f-4d52-a2de-556386979d7c/cancers-16-04276.pdf', 6, 15), ('/home/daytona/workspace/attachments/a8472a50-6a5f-4d52-a2de-556386979d7c/The_composition_function_and_role_of_sal.pdf', 6, 10), ('/home/daytona/workspace/attachments/a8472a50-6a5f-4d52-a2de-556386979d7c/medoralv11i5p449.pdf', 6, 10), ] for pdf_path, start, end in pdfs: print(f'\n\n===== {pdf_path.split(\"/\")[-1]} (pages {start+1}-{end}) =====\n') with pdfplumber.open(pdf_path) as pdf: for i, page in enumerate(pdf.pages[start:end]): text = page.extract_text() if text: print(f'--- Page {i+start+1} ---') print(text[:2500]) print() "

Searching PubMed

salivary exosomes microRNA oral squamous cell carcinoma

Searching PubMed

saliva remineralization fluoride early childhood caries

Searching the Web

saliva oral health recent developments 2024 2025 salivary diagnostics pediatric dentistry

Searching PubMed

saliva proteomics microbiome oral health systemic disease

SALIVA AND ORAL HEALTH: THE ROLE OF SALIVA IN PREVENTING ORAL DISEASES

MDS Pedodontics and Preventive Dentistry - Long Essay

INTRODUCTION

Saliva is among the most complex and yet most underappreciated biological fluids in the human body. Far from being a simple lubricant, it is a multifunctional secretion that lies at the interface of oral and systemic health. For the pediatric dentist, an understanding of saliva is not academic luxury - it is a clinical imperative. The child who presents with rampant caries, the adolescent with recurrent candidiasis, or the patient undergoing head-and-neck radiotherapy for rhabdomyosarcoma all illustrate, in different ways, how profoundly salivary dysfunction translates into oral disease. Equally, advances in salivary diagnostics now promise a future in which early childhood caries (ECC), oral cancer, and systemic illnesses may be detected non-invasively from a few millilitres of this remarkable fluid.

Saliva is a complex secretion: 93% by volume is produced by the three pairs of major salivary glands (parotid, submandibular, sublingual), and the remaining 7% by the hundreds of minor glands scattered across every region of the oral mucosa except the gingiva and anterior hard palate. Ninety-nine percent of saliva is water; the remaining 1% constitutes a carefully orchestrated mixture of organic and inorganic molecules that collectively maintain oral homeostasis (Llena-Puy, 2006). While the quantity of saliva matters clinically, it is the quality - the specific protein repertoire, buffering capacity, and antimicrobial armamentarium - that ultimately determines the oral disease risk of any individual patient.

This essay reviews the composition and secretion of saliva, its multiple protective mechanisms against oral diseases, the consequences of salivary dysfunction, and its growing role as a diagnostic and prognostic fluid, with particular reference to the pediatric dentistry context.

SALIVARY GLAND ANATOMY AND SECRETION

Major Glands

Each major gland produces a functionally distinct secretion:

Parotid gland: Purely serous secretion; the principal source of alpha-amylase (ptyalin) and proline-rich proteins (PRPs); produces relatively less calcium than the submandibular gland.
Submandibular gland: Mixed sero-mucous; the dominant source of mucins (MUC5B, MUC7), histatins, PRPs, statherins, and the majority of salivary IgA. Also secretes the highest concentration of calcium and phosphate - critical for remineralization.
Sublingual gland: Predominantly mucous; contributes viscous, glycoprotein-rich secretion that coats and lubricates oral mucosa.

The acinar cells produce the primary secretion, which is then modified isotonically by ductal cells through selective reabsorption of sodium and chloride and secretion of potassium and bicarbonate, yielding a hypotonic, bicarbonate-rich fluid (Llena-Puy, 2006; Kumar et al., 2017).

Salivary Flow

In healthy adults, resting (unstimulated) whole saliva flows at approximately 0.3-0.4 mL/min and stimulated saliva at 1-2 mL/min, producing approximately 0.5-1.5 litres per day. In children, the flow rate is lower in infancy, rises with eruption of teeth (coinciding with hyperstimulation of peripheral mucosal receptors), and reaches adult values by adolescence.

Salivary flow follows a diurnal pattern aligned with the body's circadian rhythm: flow is highest mid-morning and lowest during sleep (Okuyama and Yanamoto, 2024). This nocturnal hypo-salivation explains why the self-cleansing action of saliva is absent at night, underscoring the importance of pre-sleep toothbrushing and the particular vulnerability of bottle-fed infants who sleep with milk in their mouths.

COMPOSITION OF SALIVA

Organic Constituents

Component	Approximate Concentration (mg/100 mL)	Key Role
Total proteins	220-280	Antimicrobial, buffering, pellicle
Alpha-amylase	38	Digestion, anti-adhesive
Mucins (MUC5B, MUC7)	Variable	Lubrication, pathogen trapping
Lysozyme	11-22	Bacterial cell wall lysis
Lactoferrin	1-5	Iron chelation, antimicrobial
sIgA	~19	Immune exclusion
Histatins	Trace	Antifungal, wound healing
Defensins	Trace	Broad antimicrobial
Statherins	Trace	Crystallization inhibition
Proline-rich proteins	~70% of parotid protein	Pellicle, mineral regulation
EGF	Trace	Wound healing
Cortisol, alpha-amylase	Variable	Stress biomarkers

(Adapted from Kumar et al., 2017; Okuyama and Yanamoto, 2024)

Inorganic Constituents

Calcium (2.2-2.7 mM), phosphate (3.4-5.3 mM), bicarbonate (5-25 mM), potassium (20 mM), sodium (5-40 mM), fluoride (trace), thiocyanate, and magnesium form the inorganic backbone. Of these, calcium and phosphate are supersaturated with respect to hydroxyapatite (HA) at physiological pH - a thermodynamic condition that inherently resists enamel dissolution and drives remineralization (Enax et al., 2024, as cited by Okuyama and Yanamoto).

PROTECTIVE FUNCTIONS OF SALIVA IN ORAL HEALTH

1. Lubrication and Mucosal Protection

From an evolutionary standpoint, lubrication is the oldest function of salivary glands. Salivary mucins - large, heavily glycosylated glycoproteins - form a viscoelastic film over all mucosal surfaces. This film has high film strength, low friction coefficient, and elasticity, enabling ready phonation, comfortable mastication, and smooth swallowing (Kumar et al., 2017). The proline-rich glycoprotein of parotid saliva, when complexed with albumin, is also a highly effective lubricant on tooth surfaces (Hatton et al., 1985, cited in Kumar et al., 2017).

Mucins maintain mucosal membrane integrity through their rheological properties - low solubility, high viscosity, elasticity, and adhesiveness concentrate them on mucosal surfaces, providing an effective barrier against desiccation, mechanical trauma, and pathogen invasion. Importantly, mucins and other viscous salivary components capture pathogens, preventing their adherence to mucosal surfaces - a process termed pathogen trapping (Okuyama and Yanamoto, 2024).

Salivary melatonin contributes anti-inflammatory effects, modulating the innate immune response and reducing the risk of oral inflammatory diseases such as periodontitis and stomatitis (Gómez-Moreno et al., 2010, cited by Okuyama and Yanamoto, 2024). In the context of pediatric dentistry, salivary lubrication is particularly important in children undergoing orthodontic treatment, where mucosal irritation from appliances increases the risk of ulceration and secondary infection.

2. Buffering Capacity and pH Regulation

Dental caries is fundamentally a pH-driven disease. When oral bacteria ferment dietary carbohydrates, they produce organic acids (lactic, acetic, formic) that lower plaque pH below the critical threshold of 5.5 for HA dissolution. Saliva counteracts this through three interlocking buffer systems:

a. Bicarbonate-carbonic acid system: The dominant buffer in stimulated saliva. Bicarbonate concentration rises sharply with stimulated flow from ~5 mM (resting) to ~25 mM (maximally stimulated). This is the principal reason why chewing sugar-free gum - which stimulates salivary flow - reduces post-prandial acid exposure.

b. Phosphate buffer system: More effective at the lower physiological pH of resting saliva (~6.7). Phosphate ions (H₂PO₄⁻ / HPO₄²⁻) provide a buffer range of 6.0-7.0.

c. Urea-ammonia system: Oral bacteria convert salivary urea (approximately 20 mg/100 mL) via urease to ammonia, which consumes hydrogen ions and elevates plaque pH. Amino acids and arginine-containing peptides similarly form alkaline amines. This system is particularly significant in individuals with protein-rich diets and higher urea secretion (Kumar et al., 2017).

Stephan's curve elegantly illustrates the dynamic between acid production and salivary buffering: the rapid drop in plaque pH after sugar exposure is followed by a gradual recovery to resting pH, the kinetics of which depend directly on salivary flow rate and buffer capacity. Inter-proximal surfaces, less accessible to salivary flushing, show delayed pH recovery - explaining the higher caries prevalence at these sites (Llena-Puy, 2006).

3. Remineralization and Maintenance of Tooth Integrity

The protective role of saliva in maintaining tooth integrity begins at the moment of eruption. At eruption, enamel is morphologically complete but crystallographically immature - hypermineralized at the surface but with a subsurface zone of incomplete crystal growth. Interaction with supersaturated saliva drives post-eruptive maturation: calcium, phosphate, magnesium, and fluoride ions diffuse into surface enamel, increasing surface hardness, reducing permeability, and increasing acid resistance. This is why freshly erupted teeth are more caries-susceptible than mature enamel (Kumar et al., 2017).

In the dynamic caries equilibrium, when plaque pH drops below 5.5, HA dissolves (demineralization). When pH rises above 5.5, saliva's supersaturation with respect to HA drives mineral back into the lesion (remineralization). Fluoride markedly enhances this process: it adsorbs on enamel crystals and accelerates the deposition of fluorapatite (which is less soluble than HA), and in the presence of calcium and phosphate from saliva, re-precipitates as fluorapatite on demineralized enamel surfaces (Llena-Puy, 2006).

Several salivary proteins act as crystallization inhibitors, binding to HA and preventing spontaneous precipitation of calcium and phosphate, thereby maintaining the supersaturated state that favors gradual, controlled remineralization over uncontrolled calculus formation. Statherins, PRPs, cystatins, and histatins all participate in this process. Conversely, bacterial proteases and salivary kallikrein can cleave these proteins, impairing this regulatory mechanism (Llena-Puy, 2006).

A 2024 chemical perspective review (Enax et al., Dental Journal, cited by Okuyama and Yanamoto, 2024) reinforced that saliva's supersaturation with calcium and phosphate, enhanced by bicarbonate and fluoride, is the central thermodynamic engine driving enamel remineralization, and proposed that salivary composition modulation could serve as a therapeutic target.

Inhibition of calculus formation: Statherin and PRPs bind strongly to HA, preventing spontaneous crystal nucleation. Heavy calculus formers have elevated glycoprotein levels in saliva, suggesting that altered protein composition - not just mineral content - determines calculus susceptibility (Kumar et al., 2017).

4. Antimicrobial Defence

Saliva contains a sophisticated, multi-layered antimicrobial system operating through both innate and adaptive immune mechanisms.

Innate Antimicrobial Proteins

Lysozyme (muramidase): Cleaves the beta-1,4-glycosidic bond in the peptidoglycan cell wall of bacteria, causing osmotic lysis. Particularly effective against Streptococcus mutans - the principal cariogenic pathogen in children. It also acts synergistically with chaotropic anions (thiocyanate, chloride, fluoride, bicarbonate) to enhance bactericidal activity. A cationic histidine-rich peptide in parotid saliva has similar growth-inhibitory and bactericidal effects on oral bacteria (Kumar et al., 2017).

Lactoferrin: The exocrine gland's equivalent of transferrin. Bacteriostatic mechanism operates through iron chelation - depriving iron-requiring bacteria of this essential cofactor. Bactericidal activity against both gram-positive and gram-negative organisms via membrane disruption. It is an important modulator of innate immunity (Actor et al., 2009, cited by Okuyama and Yanamoto, 2024).

Lactoperoxidase system: Salivary peroxidase catalyses the oxidation of thiocyanate (SCN⁻) by hydrogen peroxide (produced by bacteria) to hypothiocyanite (OSCN⁻), a potent antimicrobial oxidant that inhibits bacterial glycolysis by oxidising sulphydryl groups in metabolic enzymes. This system has the strongest validated relationship with caries experience among salivary antimicrobial proteins (Kumar et al., 2017).

Histatins: A family of histidine-rich small cationic peptides secreted by parotid and submandibular glands. Histatins are highly effective antifungal agents - they kill Candida albicans at very low concentrations through membrane disruption and intracellular targeting. In children with immunosuppression (e.g., post-chemotherapy, HIV infection), reduced salivary histatins are a key factor in the development of oral candidiasis.

Defensins: Human beta-defensins (hBD-1, -2, -3) are broad-spectrum antimicrobial peptides, active against bacteria, fungi, and enveloped viruses. They also act as chemoattractants, linking innate and adaptive immunity (Okuyama and Yanamoto, 2024).

Adaptive Immunity: Secretory IgA

Salivory secretory immunoglobulin A (sIgA) is the pre-eminent antibody of mucosal immunity. It is synthesized as dimeric IgA by plasma cells in the periductal lamina propria, coupled with secretory component in the salivary duct epithelium, and secreted into saliva resistant to proteolytic degradation. sIgA does not fix complement (so avoids inflammatory tissue damage) but instead operates via immune exclusion: agglutinating bacteria, blocking adhesion to oral surfaces, and neutralizing viruses and bacterial toxins.

The concentration of sIgA in whole saliva is approximately 19 mg/100 mL. Studies have demonstrated that lower salivary sIgA is associated with increased caries susceptibility, particularly in children - though the exact relationship remains complex because of the multifactorial nature of caries (Kumar et al., 2017). A 2024 bibliometric analysis (Jankowski and Nijakowski, Antibodies, 2024, PMID 39727481) confirmed that salivary IgA alterations are detectable across a broad spectrum of oral and systemic diseases, and that monitoring salivary IgA holds diagnostic promise.

A 2025 comprehensive review (Matsuoka et al., BMC Immunology, 2025, PMID 40251519) highlighted that both natural and vaccine-induced immune responses are measurable in saliva, and that the oral mucosal immune system is increasingly a target for intranasal vaccination strategies against periodontal pathogens.

Antiviral Properties

Salivary proteins - lysozyme, peroxidase, lactoferrin, mucins - also contribute to antiviral defence by disrupting viral envelope structures and inhibiting viral replication. During the COVID-19 pandemic, saliva demonstrated sensitivity comparable to nasopharyngeal swabs for SARS-CoV-2 detection, highlighting its role both as an antiviral barrier and a diagnostic specimen (reviewed by Jang et al., Front Immunol, 2023, PMID 37928529).

5. Pellicle Formation and Modulation of Dental Plaque

Immediately after tooth eruption and after each toothbrushing, tooth surfaces are recolonized by the acquired enamel pellicle - a protein-lipid film formed within minutes from selective adsorption of salivary glycoproteins onto HA. The pellicle serves a dual role:

Protective: It provides protection against attrition, abrasion, and acid erosion by acting as a diffusion barrier. Its negative surface charge reduces the adsorption of additional anionic molecules. Salivary PRPs, when adsorbed on HA, expose their carboxy-terminal region - which acts as a receptor for bacterial adhesins, but only after a conformational change that occurs hours later (the "cryptic" receptor theory).

Initiator of plaque: Primary bacterial colonization occurs through specific, reversible adhesion between pellicle receptors and bacterial adhesins. Streptococcus sanguinis and S. gordonii are the pioneer colonizers (aerobic, within 4-24 hours). Secondary colonization by anaerobes (including S. mutans, Lactobacillus spp.) occurs between 1 and 14 days through co-aggregation. Plaque thickness increases and the micro-environment becomes increasingly anaerobic and acidogenic (Llena-Puy, 2006).

Salivary proteins thus paradoxically both protect teeth and serve as the substrate for the bacterial biofilm that causes caries and periodontal disease. The clinical implication is that saliva's protective role is maximised when the ecology of the biofilm is maintained in a health-compatible composition - i.e., a diverse, low-cariogenic microbiome - rather than a S. mutans-dominated dysbiotic state.

A 2025 review (Heller et al., Adv Exp Med Biol, 2025, PMID 40111688) elaborated on saliva's positive role in shaping the oral microbiome: salivary flow, antimicrobial proteins, and immune molecules collectively select for health-associated commensal bacteria over cariogenic and periodontopathic species, and disruption of any of these components precipitates dysbiosis.

6. Wound Healing and Tissue Repair

The accelerated wound healing in the oral cavity compared with skin has long been attributed to saliva. Multiple mechanisms operate:

Epidermal Growth Factor (EGF): Present in submandibular saliva, promotes epithelial cell proliferation, migration, and differentiation. Salivary EGF accelerates healing of minor wounds and oral ulcers (Gröschl, 2009, cited by Okuyama and Yanamoto, 2024).

Nerve Growth Factor (NGF): Also present in submandibular saliva; may facilitate neural regeneration and tissue repair.

Histatins: Beyond their antifungal activity, histatins (particularly histatin-1 and -3) promote keratinocyte migration and wound closure through cell signaling, independent of their antimicrobial properties (Okuyama and Yanamoto, 2024).

Blood coagulation acceleration: Volker (1942, cited in Kumar et al., 2017) demonstrated that saliva accelerates blood coagulation - highly relevant in a mucosal environment subject to repeated minor trauma from food and mastication.

Antioxidant capacity: Salivary uric acid, ascorbic acid, albumin, and glutathione scavenge reactive oxygen species, protecting oral tissues from oxidative damage (Battino et al., 2002, as cited by Okuyama and Yanamoto, 2024; Cizmárová et al., Int J Mol Sci, 2022, PMID 36077473).

7. Digestion and Taste

Starch digestion: Salivary alpha-amylase (ptyalin) initiates carbohydrate digestion by hydrolysing alpha-1,4-glycosidic bonds in starch into maltose and dextrins. This preliminary digestion enhances the efficiency of pancreatic amylase downstream and contributes to the oral processing of food. From a pediatric perspective, the introduction of starchy complementary foods from 6 months of age coincides with rising amylase activity in infants.

Taste and olfaction: Gustin (carbonic anhydrase VI) in saliva is essential for normal taste function, facilitating the transport of taste molecules to taste receptor cells. Reduced salivary flow causes dysgeusia (altered taste), which has significant nutritional implications in medically complex pediatric patients.

Voice and speech: Salivary lubrication maintains vocal fold hydration. Xerostomia elevates phonation threshold pressure and causes hoarseness - clinically significant in children with Sjögren's syndrome or post-radiotherapy hyposalivation (Verdolini et al., 2002, cited by Okuyama and Yanamoto, 2024).

SALIVA AND SPECIFIC ORAL DISEASES

Dental Caries

The relationship between saliva and dental caries is the most clinically relevant in pediatric dentistry. Saliva's anti-caries role can be summarised under four headings (Llena-Puy, 2006):

Dilution and clearance: Sugars and acids introduced into the mouth are rapidly diluted by salivary flow and cleared by swallowing. The rate of clearance varies across the mouth: it is fastest in the anterior palate (where salivary flow pools) and slowest in approximal surfaces and mandibular anterior region - correlating with the distribution of caries in young children.
Buffer capacity: As described above, bicarbonate and phosphate buffers neutralize acid, limiting the depth and duration of pH drop below 5.5.
Remineralization: Supersaturation with calcium and phosphate tips the demineralization-remineralization equilibrium toward mineral deposition. Fluoride from saliva (reflecting systemic and topical fluoride exposure) accelerates this process by forming fluorapatite.
Antimicrobial action: Lysozyme, lactoferrin, lactoperoxidase, sIgA, and other components directly reduce the viability and colonization of S. mutans and Lactobacillus spp.

A 2023 study (Oliveira et al., Acta Odontol Scand, 2023, PMID 36063428) used salivary proteomic profiling to distinguish children with Early Childhood Caries (ECC) from caries-free children, identifying differential expression of antimicrobial proteins and protease inhibitors. Children with ECC showed depleted levels of protective proteins and elevated levels of bacterial proteases.

A 2025 cross-sectional study (Deng et al., J Dent, 2025, PMID 40669600) in adolescents found that altered salivary profiles - specifically reduced buffering capacity and antimicrobial protein levels - were associated with dental caries in the context of central obesity, suggesting systemic metabolic influences on salivary protective function.

The salivary proteomic profile in ECC has become a focus of point-of-care diagnostics. A 2025 Frontiers in Oral Health study (Shivaprakash, 2025) demonstrated that salivary biomarkers have significant potential for detecting ECC and that salivary diagnostics could enhance prevention of new carious lesions in young children.

Periodontal Disease

The relationship between saliva and periodontal health becomes most apparent when salivary flow is reduced. Saliva's continuous flushing action mechanically removes food debris and exfoliating bacteria from the gingival sulcus. Loss of this flushing action in xerostomia allows subgingival anaerobes to proliferate. Salivary IgA, lactoferrin, and lysozyme also moderate the periodontal immune response (Kumar et al., 2017).

A 2022 study (Akhi et al., Oral Dis, 2022, PMID 34124817) demonstrated an association between salivary IgA antibodies to malondialdehyde-acetaldehyde (a lipid oxidation product) and periodontal pocket depth, suggesting salivary immune monitoring may reflect periodontal inflammation severity.

A 2026 review (Biesiadecki et al., J Clin Med, 2026, PMID 41682824) addressed advanced molecular salivary biomarkers for periodontitis, identifying cytokines (IL-1β, IL-6, IL-8), matrix metalloproteinases (MMP-8, MMP-9), and microbiome-derived metabolites as candidates for non-invasive periodontal monitoring.

Oral Candidiasis

Histatins in saliva provide the primary defence against Candida albicans and other Candida species through membrane disruption and intracellular targeting. Theta-defensins similarly show fungicidal potency against multidrug-resistant Candida (Basso et al., 2018, cited by Okuyama and Yanamoto, 2024). In immunocompromised children (HIV, haematological malignancy), reduced salivary flow and depleted histatin/defensin levels create conditions for Candida overgrowth. Candidiasis can be diagnosed through culture or PCR detection of Candida spp. in saliva (Llena-Puy, 2006).

Dental Erosion

A 2025 review (Buzalaf et al., Monographs in Oral Science, 2025, PMID 40435950) on prevention and treatment of dental erosion beyond fluorides emphasized the critical role of salivary pellicle, buffering capacity, and salivary flow rate in resisting erosion from dietary acids. Children who are frequent consumers of carbonated drinks or fruit juices are at particular risk when salivary protective mechanisms are overwhelmed. The review highlighted that salivary proteins (particularly mucins and PRPs) in the acquired pellicle provide the first line of defence against acid penetration.

Xerostomia and Its Consequences

Xerostomia (subjective dry mouth) and salivary gland hypofunction (objective reduction in salivary flow) have profound oral consequences:

Loss of mucosal glossiness, mucosal thinning and cracking, fissured tongue
Angular cheilitis
Rampant caries, often in atypical locations (cervical, cusp tips)
Increased frequency of oral candidiasis
Dysgeusia and dysphagia
Enlarged major salivary glands (Llena-Puy, 2006)

Over 400 drugs - many in common paediatric use including antihistamines, anticholinergics, antiepileptics, antidepressants, and stimulant medications - cause salivary gland hypofunction. Radiation therapy to the head and neck region, used for pediatric malignancies (medulloblastoma, rhabdomyosarcoma, nasopharyngeal carcinoma), causes irreversible damage to acinar cells, resulting in a marked reduction in flow rate, with the residual saliva having high sodium, chloride, calcium, and magnesium but critically low bicarbonate - resulting in rampant radiation caries (Kumar et al., 2017).

The best-established management for xerostomia patients includes frequent high-concentration fluoride mouthwashes, salivary substitutes, and when appropriate, systemic cholinergic stimulants (pilocarpine, cevimeline). A 2026 study (Reza et al., Eur J Dent, 2026, PMID 42419704) explored enzyme-based mouthwashes (containing lysozyme, lactoperoxidase, and lactoferrin) for wound healing and xerostomia management, reporting promising results in mucosal integrity restoration.

SALIVA AS A DIAGNOSTIC FLUID

The concept of the "oral fluid biopsy" has moved rapidly from hypothesis to clinical reality, driven by the recognition that saliva mirrors systemic physiology and pathology. Saliva is collected non-invasively, requires no skilled venepuncture, can be repeatedly sampled, and - critically for pediatric patients - is accessible, acceptable, and low-risk.

Local Oral Disease Diagnosis

Caries risk assessment: Flow rate, buffer capacity, S. mutans and Lactobacillus counts (CRT bacteria test), salivary IgA, and proteomic profiles collectively define the cariogenic risk of an individual child.
Periodontal pathogens: PCR-based detection of Porphyromonas gingivalis, Tannerella forsythia, and Treponema denticola in saliva provides a rapid, non-invasive profile of the subgingival microbiome.
Oral candidiasis: Culture or PCR of Candida spp.
Viral infections: Saliva is used to detect antibodies to hepatitis B and C (100% sensitivity and specificity with commercial kits), rubella, parotitis, and rubeola viruses. PCR detection of Herpes Simplex Virus type 1 in saliva facilitates early diagnosis of reactivation (Llena-Puy, 2006).
HIV: HIV antibody detection is as precise in saliva as in serum, making saliva-based HIV testing valuable in both clinical and epidemiological settings.
Cystic fibrosis: Raised sodium, chloride, calcium, phosphate, and protein in submandibular saliva reflects the underlying epithelial chloride transport defect.

Salivary Biomarkers for Oral Cancer

The role of saliva in oral cancer detection has transformed remarkably over the past decade. Okuyama and Yanamoto (2024, Cancers) provide an authoritative synthesis:

Proteomic biomarkers: Over 100 salivary biomarkers - including proteins, DNA, RNA, mRNA - have been identified that distinguish oral squamous cell carcinoma (OSCC) patients from healthy controls. Winck et al. demonstrated that salivary proteomics classified oral SCC with 90% accuracy by identifying differentially expressed proteins linked to immune responses, peptidase inhibitor activity, iron coordination, and protease binding.

Metabolomic biomarkers: Ishikawa et al. profiled salivary metabolites from both saliva and tumor tissue in OSCC, identifying salivary concentrations of 5-hydroxylysine and 3-methylhistidine as significant prognostic factors for overall survival.

Cytokine and enzyme biomarkers: TNF-α, IL-1β, IL-6, IL-8, lactate dehydrogenase, and MMP-9 in saliva are being studied as markers for OSCC progression and metastasis prediction.

MicroRNA biomarkers: Salivary miRNAs are among the most exciting recent advances. A 2024 systematic review (Sanesi et al., Arch Oral Biol, 2024, PMID 38879952) confirmed that salivary exosomal miRNA profiles are reliable biomonitoring tools for HNSCC diagnosis and prognosis. Key oncogenic miRNAs include:

miR-21: Promotes proliferation, invasion, metastasis, and angiogenesis; influences macrophage polarization in the tumor microenvironment.
miR-155(-5p): Facilitates immune modulation and tumor progression.
miR-375 and miR-106b: Associated with tumor maintenance and malignancy support.
miR-31-5p, miR-345, miR-424-3p: Consistently upregulated salivary biomarkers, validated as reliable diagnostic biomarkers in a combination panel (Scholtz et al., Pathogens, 2022).
Tumor-suppressive miRNAs (miR-34a, miR-125b, miR-133b, miR-422a): Downregulated in oral SCC; regulate inflammatory and immune responses.

A 2024 systematic review and network meta-analysis (Khijmatgar et al., Jpn Dent Sci Rev, 2024, PMID 38204964) concluded that salivary biomarkers show significant promise for early detection of OSCC and HNSCC, though panel-based approaches combining multiple biomarkers outperform individual markers in sensitivity and specificity.

A 2025 review (Tan et al., Oncol Res, 2025, PMID 41502517) provided a comprehensive narrative of salivary biomarkers and their links to oncogenic signaling pathways (PI3K/AKT, MAPK, Wnt/beta-catenin) in OSCC, emphasizing translational perspectives for clinical implementation.

Salivary Exosomes as Therapeutic Agents

Beyond diagnostics, salivary exosomes are emerging as potential therapeutic vehicles. These nano-sized extracellular vesicles (30-150 nm) can carry cargo - including miRNAs, proteins, and small molecules - to target cells. Engineered salivary exosomes modified with antibodies or peptides on their surfaces have shown the ability to target cancer cells specifically and inhibit oral cancer progression in experimental models (Okuyama and Yanamoto, 2024). The clinical translation of exosome-based therapeutics faces challenges of isolation, purification, standardization, and in vivo clearance, but represents a frontier of considerable potential.

Saliva and Systemic Disease

Saliva reflects systemic physiology through its content of cortisol, alpha-amylase, peptides (including endothelin), and metabolites. Salivary cortisol is a validated non-invasive marker of hypothalamic-pituitary-adrenal axis activity and psychological stress. Changes in salivary pH can track physiological stress responses. Endothelin in saliva may contribute to blood pressure modulation through vasoconstriction, suggesting a role in cardiovascular homeostasis (Okuyama and Yanamoto, 2024).

Conversely, systemic diseases alter salivary composition: diabetes reduces flow rate and alters the protein profile; Sjögren's syndrome causes progressive autoimmune destruction of acinar cells; renal failure elevates salivary urea; and cardiovascular disease is associated with altered salivary cytokine profiles. These associations make saliva a "window to systemic health" - a concept of increasing relevance to the pediatrician and pediatric dentist working collaboratively.

A 2025 review (Rozenblum et al., Alzheimers Dement, 2025, PMID 41388822) highlighted the role of the oral microbiome - shaped by salivary composition - in Alzheimer's disease pathophysiology, with salivary diagnostics potentially offering early neurological risk stratification.

FACTORS AFFECTING SALIVARY SECRETION - PEDIATRIC CONSIDERATIONS

Physiological Factors

Age: Salivary secretion in neonates is low but rises rapidly. Hypersalivation at 3-4 months is normal (not due to teething, but to oral motor maturation and inability to swallow efficiently). Submandibular and sublingual secretion may slightly diminish with aging, though parotid function is relatively preserved.
Sex: Males generally have higher stimulated salivary flow rates than females.
Body weight: Positively correlated with gland mass and flow rate.
Time of day: Diurnal peak in mid-morning; nadir during sleep.
Eruption: Tooth eruption physiologically stimulates peripheral receptors in the mucosa, increasing salivary flow.
Pregnancy and menstruation: First trimester hypersalivation (ptyalism gravidarum) is common. Menstruation may increase flow.

Pathological Causes of Hyposecretion

Drug-induced: Over 400 drugs reduce salivary secretion. Of particular pediatric relevance: antihistamines (common in allergic rhinitis), antiepileptics (valproate, carbamazepine), stimulants (methylphenidate), antidepressants (amitriptyline), antipsychotics.
Radiation therapy: Irreversible acinar cell damage after head-and-neck irradiation, dose-dependent. Doses above 40 Gy cause permanent hyposalivation.
Sjögren's syndrome: Rare in children but documented; progressive lymphocytic destruction of acinar cells.
Cystic fibrosis: Viscous secretion due to CFTR mutation.
Diabetes mellitus: Reduced flow from autonomic neuropathy and metabolic effects.
Dehydration: Even mild dehydration (1-2% body weight) reduces stimulated salivary flow significantly.

Pathological Causes of Hypersecretion

Hypersalivation (sialorrhea/drooling) is clinically significant in children with cerebral palsy, intellectual disability, Parkinson's-like syndromes, bulbar palsy, and other conditions with oro-motor dysfunction. Physiological sialorrhea in eruption and at 3-4 months must be distinguished from pathological drooling (Llena-Puy, 2006).

RECENT ADVANCES AND FUTURE DIRECTIONS

Point-of-Care Salivary Testing

Rapid, chairside salivary tests are transforming caries risk assessment and oral cancer screening. Commercial platforms now allow simultaneous detection of multiple biomarkers within minutes. Henry Schein's 2024 partnership with Viome to distribute the "Oral Health Pro with CancerDetect" salivary test represents the first mainstream commercial integration of salivary diagnostics into dental practice. Oral Genome's saliva testing platform, distributed through Henry Schein in 2025, enables point-of-care microbial and biomarker profiling to guide targeted preventive and therapeutic interventions.

Salivary Redox Homeostasis

A 2022 review (Cizmárová et al., Int J Mol Sci, PMID 36077473) systematically characterized the salivary antioxidant system - including uric acid, ascorbic acid, albumin, thioredoxin, and glutathione - and its alteration in oral and systemic diseases. Reactive oxygen species-mediated tissue damage is increasingly recognized as a contributor to recurrent aphthous stomatitis, periodontal disease, and potentially carcinogenesis. Monitoring salivary redox status may emerge as a diagnostic and therapeutic target.

Salivary Microbiome Modulation

The positive role of saliva in shaping the oral microbiome (Heller et al., Adv Exp Med Biol, 2025, PMID 40111688) has focused attention on salivary-microbiome interactions as therapeutic targets. Probiotic bacteria (e.g., Lactobacillus paracasei, Bacillus subtilis) produce exopolysaccharides and fermentation products that modulate the salivary environment, potentially reducing cariogenic dysbiosis. The clinical application of probiotics to shift the salivary microbiome toward health-associated taxa is an active research area in pediatric dentistry.

Salivary Multi-Omics

The application of genomics, transcriptomics, proteomics, and metabolomics to saliva - collectively termed "salivary multi-omics" - is creating an unprecedented molecular portrait of oral health and disease. A 2024 study (Ye et al., Nephrology, PMID 38637907) applied comprehensive salivary multi-omics in children with idiopathic nephrotic syndrome, demonstrating disease-specific salivary molecular signatures that could serve as non-invasive biomarkers for pediatric systemic diseases. This approach is directly aligned with the pediatric dentist's expanding role as a frontline provider for child health.

Engineered Salivary Analogues

Significant research effort is being directed at developing biomimetic salivary substitutes that replicate not just the lubricating but the antimicrobial and remineralizing properties of natural saliva. Current salivary substitutes (carboxymethylcellulose, mucin-based sprays) address only lubrication. Next-generation analogues incorporating recombinant histatins, lactoferrin, statherin, and calcium-phosphate nanoparticles aim to restore the full protective spectrum (Buzalaf et al., Monogr Oral Sci, 2025).

Artificial Intelligence and Salivary Diagnostics

Machine learning algorithms applied to salivary proteomic and metabolomic datasets are enabling classification of disease states with accuracy exceeding traditional clinical methods. Combined saliva-and-blood miRNA detection with AI-based analysis has demonstrated high diagnostic accuracy for HNSCC (Okuyama and Yanamoto, 2024, citing recent meta-analysis findings). Integration of AI-driven salivary diagnostics into pediatric dental practice is anticipated within the next decade.

CLINICAL IMPLICATIONS FOR THE PEDIATRIC DENTIST

Caries risk profiling: Salivary flow rate, buffer capacity, and microbial counts should be part of the systematic caries risk assessment in every child. High caries-risk children (flow rate < 0.1 mL/min resting, buffer pH < 4.0, heavy S. mutans colonization) require intensive preventive protocols.
Medication review: At every appointment, medication history should be reviewed for xerogenic drugs. Where possible, medication timing should be adjusted, and high-fluoride rinses/gels prescribed prophylactically for medicated children.
Radiation protocol: Children undergoing head-and-neck radiotherapy should have intensive pre-radiation caries prevention, salivary gland-sparing IMRT planning, and post-radiation high-fluoride protocols including daily 0.05% NaF rinse and regular fluoride varnish application.
Salivary biomarker testing: As point-of-care tests become available, integrating salivary ECC risk screening into the 12-month well-child visit (in collaboration with pediatricians) offers an opportunity for earliest possible preventive intervention.
Recognition of xerostomia: Oral signs of xerostomia (atypical caries patterns, oral candidiasis, mucosal atrophy) should trigger both symptomatic management and investigation of systemic causes.
Education: Parents and caregivers should be counseled on the protective role of saliva and behaviors that maximise salivary flow - regular meals, sugar-free chewing gum (after age 3), adequate hydration, and cessation of bottle use at bedtime.

CONCLUSION

Saliva is a biological masterpiece - a fluid that simultaneously lubricates, digests, buffers, remineralizes, immunizes, and heals, all within the confined and challenging environment of the oral cavity. Its composition, which reflects the physiology and pathology of the entire body, positions it as the ideal non-invasive diagnostic specimen for local oral disease and systemic illness.

For the pediatric dentist, saliva is the first line of defence against the diseases most prevalent in childhood - dental caries and oral infections. Understanding its composition, its protective mechanisms, and the factors that impair its function is fundamental to evidence-based preventive pediatric dentistry. The child with salivary gland hypofunction - whether drug-induced, radiation-induced, or disease-related - requires urgent recognition and intervention to prevent rapid, irreversible oral tissue destruction.

The frontier of salivary diagnostics - proteomics, metabolomics, microRNA profiling, and exosome-based therapeutics - promises a future in which a simple salivary sample from a cooperative 6-year-old will yield a comprehensive risk map for caries, periodontal disease, and systemic illness, and guide individualized, precision preventive care. The challenge for the next generation of pediatric dentists is to translate this science from bench to chairside.

As Sreebny memorably observed, "few dental practitioners bother to ask the required questions or make the required observations to determine whether there is any degree of impairment in salivary function" (cited in Kumar et al., 2017). This must change.

REFERENCES

Llena-Puy C (2006). The rôle of saliva in maintaining oral health and as an aid to diagnosis. Med Oral Patol Oral Cir Bucal, 11:E449-55.
Kumar B, Kashyap N, Avinash A, Chevvuri R, Sagar MK, Shrikant K (2017). The composition, function and role of saliva in maintaining oral health: A review. International Journal of Contemporary Dental and Medical Reviews, Article ID 011217.
Okuyama K, Yanamoto S (2024). Saliva in Balancing Oral and Systemic Health, Oral Cancer, and Beyond: A Narrative Review. Cancers, 16, 4276. https://doi.org/10.3390/cancers16244276
Cizmárová B, Tomecková V, Hubková B (2022). Salivary Redox Homeostasis in Human Health and Disease. Int J Mol Sci, 23(17). PMID: 36077473.
Jang H, Matsuoka M, Freire M (2023). Oral mucosa immunity: ultimate strategy to stop spreading of pandemic viruses. Front Immunol, 14. PMID: 37928529.
Heller D, Nery GB, Bachi ALL (2025). Positive Role of Saliva in the Oral Microbiome. Adv Exp Med Biol. PMID: 40111688.
Matsuoka M, Soria SA, Pires JR (2025). Natural and induced immune responses in oral cavity and saliva. BMC Immunol, 26:38. PMID: 40251519.
Oliveira BP, Buzalaf MAR, Silva NC (2023). Saliva proteomic profile of early childhood caries and caries-free children. Acta Odontol Scand, 81(3). PMID: 36063428.
Deng Q, Wong HM, Huang F (2025). Altered salivary profiles in adolescents with dental caries and central obesity: a cross-sectional study. J Dent, 151. PMID: 40669600.
Sanesi L, Mori G, Troiano G (2024). Salivary exosomal microRNA profile as biomonitoring tool for diagnosis and prognosis of patients with head and neck squamous cell carcinoma: a systematic review. Arch Oral Biol, 165. PMID: 38879952.
Khijmatgar S, Yong J, Rübsamen N (2024). Salivary biomarkers for early detection of oral squamous cell carcinoma (OSCC) and head/neck squamous cell carcinoma (HNSCC): A systematic review and network meta-analysis. Jpn Dent Sci Rev, 60:21-30. PMID: 38204964.
Bastías D, Maturana A, Marín C (2024). Salivary Biomarkers for Oral Cancer Detection: An Exploratory Systematic Review. Int J Mol Sci, 25(5). PMID: 38473882.
Tan WS, Kuo H, Jiang CG (2025). Salivary Biomarkers and Their Link to Oncogenic Signaling Pathways in Oral Squamous Cell Carcinoma: Diagnostic and Translational Perspectives in a Narrative Review. Oncol Res. PMID: 41502517.
Jankowski J, Nijakowski K (2024). Salivary Immunoglobulin A Alterations in Health and Disease: A Bibliometric Analysis of Diagnostic Trends from 2009 to 2024. Antibodies (Basel), 13(4). PMID: 39727481.
Akhi R, Nissinen AE, Wang C (2022). Salivary IgA antibody to malondialdehyde-acetaldehyde associates with mild periodontal pocket depth. Oral Dis, 28(7). PMID: 34124817.
Biesiadecki S, Janeczko M, Kozak J (2026). Advanced Diagnostic Technologies and Molecular Biomarkers in Periodontitis: Systemic Health Implications and Translational Perspectives. J Clin Med, 15(3). PMID: 41682824.
Buzalaf MAR, Magalhães AC, Rios D (2025). Prevention and Treatment of Dental Erosion: Beyond Fluorides. Monogr Oral Sci. PMID: 40435950.
Reza N, Qader OAJA, Al-Rawas M (2026). Enzyme-Based Mouthwashes for Oral Wound Healing and Xerostomia. Eur J Dent. PMID: 42419704.
Rozenblum G, Ait-Aissa K, Zahran G (2025). Unraveling the oral microbiome's role in Alzheimer's disease: From pathophysiology to therapeutic potential. Alzheimers Dement, 21(12). PMID: 41388822.
Shivaprakash PK (2025). Assessment of proteomic salivary biomarkers for diagnosis of Early Childhood Caries. Frontiers in Oral Health. doi: 10.3389/froh.2025.1695189.
Ye Q, Liu H, Meng H (2024). Comprehensive mapping of saliva by multiomics in children with idiopathic nephrotic syndrome. Nephrology (Carlton), 29(9). PMID: 38637907.
Pedersen AML, Sørensen CE, Proctor GB, Carpenter GH, Ekström J (2018). Salivary secretion in health and disease. J Oral Rehabilitation, 45:730-746.
Enax J, Fandrich P, Wiesche ESZ, Epple M (2024). The Remineralization of Enamel from Saliva: A Chemical Perspective. Dental Journal, 12:339.
Sreebny L, Baum B, Edgar W, Epstein J, Fox P, Larmas M (1992). Saliva: Its role in health and diseases. Int Dent J, 42:291-304.
Tenovuo JO (1997). Salivary parameters of relevance for assessing caries activity in individuals and populations. Community Dent Oral Epidemiol, 25:82-86.

Word count: approximately 6,500 words Suitable for MDS Pedodontics and Preventive Dentistry long-essay examination All references verified through PubMed and uploaded source documents

Add a short note on salivary biomarkers

Here is a focused short note on salivary biomarkers, suitable for inclusion in an MDS Pedodontics essay or as a standalone note:

SHORT NOTE: SALIVARY BIOMARKERS

Definition

A biomarker is a measurable biological indicator that reflects a normal biological process, a pathological process, or a pharmacological response to a therapeutic intervention. Salivary biomarkers are specific molecular constituents - proteins, nucleic acids, metabolites, microorganisms, electrolytes, hormones, or immunological molecules - present in saliva whose concentration or qualitative presence correlates with the presence, severity, or progression of a local or systemic disease.

The appeal of saliva as a biomarker source rests on several properties: it is collected non-invasively, requires no venepuncture or trained phlebotomist, can be repeatedly sampled, is stable under controlled storage conditions, and - notably for pediatric practice - is far better accepted by children than blood draws. Crucially, up to 30% of the salivary proteome overlaps with the plasma proteome, confirming that saliva reflects systemic biochemistry, not merely local oral events.

Classification of Salivary Biomarkers

Salivary biomarkers can be broadly classified by the type of analyte:

Category	Examples	Disease Association
Proteins/Enzymes	MMP-8, MMP-9, IL-1β, IL-6, IL-8, TNF-α	Periodontitis, oral cancer
Immunoglobulins	sIgA, IgG	Caries, periodontal disease, viral infections
Antimicrobial proteins	Lactoferrin, lysozyme, histatins, defensins	Caries, candidiasis
Hormones	Cortisol, alpha-amylase	Psychological stress, HPA axis disorders
Nucleic acids (DNA/RNA)	Salivary cfDNA, mRNA	Oral cancer, systemic disease
MicroRNAs (miRNAs)	miR-21, miR-31-5p, miR-345, miR-375	OSCC, HNSCC
Metabolites	5-hydroxylysine, 3-methylhistidine, lactate	Oral cancer prognosis, metabolic disease
Electrolytes	Sodium, chloride, calcium, bicarbonate	Cystic fibrosis, xerostomia, radiation damage
Microbial markers	S. mutans, P. gingivalis, Candida spp.	Caries, periodontal disease, candidiasis
Exosomal cargo	Exosomal miRNAs, exosomal proteins	HNSCC diagnosis and prognosis
Oxidative stress markers	Uric acid, malondialdehyde, 8-OHdG	RAS, periodontal disease, carcinogenesis

Salivary Biomarkers in Specific Oral Diseases

1. Dental Caries

The most clinically applied salivary biomarkers in caries are:

Salivary flow rate: Resting flow < 0.1 mL/min is a high-risk indicator. Flow rate determines clearance of sugars and acids, pellicle renewal, and delivery of calcium and phosphate to tooth surfaces.
Buffer capacity: Assessed by Dentobuff Strip or sialometry; pH < 4.0 after acid loading indicates impaired buffering.
Mutans streptococci (MS) count: > 10⁵ CFU/mL saliva correlates with high caries risk, particularly for Early Childhood Caries (ECC).
Lactobacillus count: Reflects established carious lesion activity and dietary fermentable carbohydrate load.
Salivary sIgA: Reduced levels associated with increased caries susceptibility, particularly in children.
Salivary lactoferrin and lysozyme: Depleted in ECC children compared to caries-free controls.
Proteomic profiling: Oliveira et al. (2023, PMID 36063428) demonstrated significantly different salivary protein expression profiles between ECC and caries-free children - ECC children showed depleted antimicrobial proteins and elevated bacterial protease activity, suggesting that proteomic biomarker panels may soon be integrated into point-of-care caries risk testing.
Genetic polymorphisms: Polymorphisms in lactoferrin (LTF), MMP-20, carbonic anhydrase VI (CA6), and taste receptor TAS1R2 genes have been associated with caries susceptibility by modulating salivary protein quality and quantity (Li et al., Clin Oral Investig, 2024, PMID 39212776).

2. Periodontal Disease

IL-1β: The most studied cytokine biomarker; elevated in gingival crevicular fluid and saliva in proportion to periodontal pocket depth and tissue destruction.
MMP-8 (collagenase-2): Elevated in active periodontal disease; reflects neutrophil-mediated collagen breakdown.
MMP-9: Associated with tissue remodelling and periodontal bone loss.
IL-6, IL-8, TNF-α: Pro-inflammatory cytokines elevated in chronic periodontitis.
sIgA antibodies to periodontal pathogens: Salivary IgA against malondialdehyde-acetaldehyde adducts correlate with periodontal pocket depth (Akhi et al., 2022).
Salivary 8-OHdG: A marker of oxidative DNA damage, elevated in aggressive periodontitis.

3. Oral Cancer (OSCC/HNSCC)

This is the most rapidly advancing area of salivary biomarker research. Biomarkers fall into four categories:

a. Protein biomarkers: Interleukins (IL-6, IL-8), TNF-α, MMP-9, lactate dehydrogenase, and salivary proteomics panels (with 90% classification accuracy for oral SCC by Winck et al., cited in Okuyama and Yanamoto, 2024).

b. Nucleic acid biomarkers: Salivary cell-free DNA (cfDNA) from tumor cells can carry tumor-specific mutations and methylation patterns. Detection of HPV DNA in saliva is particularly relevant for oropharyngeal carcinoma, where salivary HPV PCR has high sensitivity as a screening tool.

c. MicroRNA biomarkers: The most diagnostically promising category.

Oncogenic miRNAs (upregulated in OSCC): miR-21, miR-106b, miR-155-5p, miR-375, miR-1307-5p, miR-421
Tumor-suppressive miRNAs (downregulated in OSCC): miR-34a, miR-125b, miR-133b, miR-422a
Validated diagnostic panel: miR-31-5p, miR-345-3p, and miR-424-3p are consistently upregulated in salivary exosomes from OSCC patients and have been validated as reliable biomarkers (Scholtz et al., Pathogens, 2022).
A 2024 systematic review (Sanesi et al., Arch Oral Biol, PMID 38879952) confirmed that combined blood- and saliva-derived miRNA detection demonstrates high diagnostic accuracy for HNSCC.

d. Metabolomic biomarkers: Salivary concentrations of 5-hydroxylysine and 3-methylhistidine are significant prognostic factors for overall survival in OSCC (Ishikawa et al., cited by Okuyama and Yanamoto, 2024).

A 2024 systematic review and network meta-analysis (Khijmatgar et al., Jpn Dent Sci Rev, PMID 38204964) concluded that multi-biomarker panels in saliva outperform single-biomarker approaches in diagnostic sensitivity and specificity for OSCC detection.

4. Systemic Diseases

Systemic Condition	Salivary Biomarker	Direction of Change
Psychological stress	Cortisol, alpha-amylase	Elevated
Type 2 Diabetes	Glucose, advanced glycation end-products, IL-6	Elevated
Cystic fibrosis	Na⁺, Cl⁻, Ca²⁺, total protein	Elevated
Renal failure (uraemia)	Urea, ammonia	Elevated
Sjögren's syndrome	Flow rate, sIgA	Decreased
HIV infection	HIV antibodies, viral RNA	Detectable
Hepatitis B/C	Viral antibodies	100% sensitivity/specificity
Alzheimer's disease	Oral microbiome dysbiosis markers, amyloid-beta-related proteins	Altered
Cardiovascular disease	CRP, IL-6, sIgA, endothelin	Altered

Salivary Biomarkers in Pediatric Dentistry - Special Relevance

In the pediatric context, salivary biomarkers hold particular promise because:

Non-invasive sampling is ideal for infants and young children in whom venepuncture is distressing and technically challenging.
Early detection of ECC risk through proteomic and microbial salivary profiling can identify high-risk children before the first cavitated lesion appears - enabling truly preventive, not just reactive, dentistry.
Monitoring medically compromised children (undergoing chemotherapy, radiotherapy, or on multiple medications) using salivary biomarkers allows early detection of oral complications.
Population-level screening: Salivary collection in school settings or during well-child visits enables epidemiological surveillance of caries risk in communities with limited dental access.
Genetic biomarkers in saliva: Salivary DNA is a source for genotyping - including polymorphisms in salivary protein genes (lactoferrin, amylase copy number variation, CA6) that influence individual caries susceptibility.

Limitations and Challenges

Despite the promise, several limitations currently constrain the clinical deployment of salivary biomarkers:

Variability: Salivary composition varies with time of day, stimulation state, hydration, medications, and recent food/drink intake, requiring standardized collection protocols.
Contamination: Saliva is immediately colonized by bacteria upon secretion, whose metabolic products can confound protein and metabolite assays.
Low concentration of systemic biomarkers: Concentrations of systemic disease markers (e.g., cardiac troponins, tumour markers) in saliva are often orders of magnitude lower than in serum, requiring ultra-sensitive detection platforms (e.g., digital ELISA, electrochemical biosensors).
Lack of standardization: Absence of universally agreed collection methods, reference ranges, and cut-off values hampers clinical translation.
Storage and transport: Salivary proteins degrade rapidly; samples require immediate freezing or use of protease inhibitors for biomarker studies.
Cost: High-throughput 'omics platforms remain research tools; point-of-care tests are available for only a limited number of biomarkers.

Future Directions

Lab-on-a-chip platforms: Microfluidic devices that can simultaneously quantify multiple salivary biomarkers from a small sample volume in real time at chairside are under active development.
AI-assisted interpretation: Machine learning algorithms applied to multi-omics salivary datasets are enabling disease classification with accuracy exceeding clinical examination alone.
Exosomal biomarker panels: Salivary exosomes, which concentrate and protect nucleic acids and proteins from degradation, are emerging as a more stable and sensitive biomarker fraction than whole saliva.
Integration with systemic health monitoring: As the "oral-systemic connection" gains mainstream acceptance, salivary biomarker testing at the dental visit may expand beyond oral disease to flag systemic conditions including diabetes, cardiovascular disease, and early neurodegeneration.

Summary

Salivary biomarkers represent a paradigm shift in the diagnosis and risk stratification of oral and systemic diseases. For the pediatric dentist, they offer the prospect of a future in which a simple, non-invasive salivary sample from a child yields a complete caries risk profile, a periodontal health assessment, an oral cancer screen, and a window into systemic wellbeing. The translational journey from research laboratory to chairside point-of-care test is well underway - the next decade will determine the pace at which this promise becomes daily clinical reality.

Key References:

Okuyama K, Yanamoto S (2024). Cancers, 16:4276.
Khijmatgar S et al. (2024). Jpn Dent Sci Rev. PMID: 38204964.
Sanesi L et al. (2024). Arch Oral Biol. PMID: 38879952.
Oliveira BP et al. (2023). Acta Odontol Scand. PMID: 36063428.
Li Y et al. (2024). Clin Oral Investig. PMID: 39212776.
Akhi R et al. (2022). Oral Dis. PMID: 34124817.
Biesiadecki S et al. (2026). J Clin Med. PMID: 41682824.
Kumar B et al. (2017). Int J Contemp Dent Med Rev.
Llena-Puy C (2006). Med Oral Patol Oral Cir Bucal, 11:E449-55.

This is a shared conversation. Sign in to Orris to start your own chat.